| Is it possible to prevent recurrent Crohn's disease with medical or surgical interventions? | |
| | |
MedLine Citation:
|
PMID: 8819803 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
While surgery for Crohn's disease is usually effective initially, its long-term benefits may be diminished by the risk of recurrent disease. In our studies, we have observed symptomatic recurrence rates of 47% and endoscopic recurrence rates of 75% at 3 years. As a result, there has been considerable interest in strategies aimed at decreasing recurrence. Unfortunately, surgical manoeuvers have had little effect on recurrence rates. There are conflicting data on the effect of resection margin length and microscopic disease at the resection margin, probably due to the fact that most data are derived from retrospective studies. Differences in anastomotic technique also appear to have little effect on the recurrence rate. On the other hand, there are now data from two randomized controlled trials supporting the use of 5-aminosalicylic acid postoperatively. In a study performed at the University of Toronto and Mayo Clinic, of 163 patients who were randomized to 5-aminosalicylic acid (Salofalk) 3.0 g/day or placebo, the relative risk of a symptomatic recurrence was 0.628 in the treatment group compared to those in the control group. For compliant patients, the risk reduction was even greater with a RR of 0.532. A similar reduction in the endoscopic recurrence rate was observed. Caprilli and colleagues reported similar results in patients receiving 2.4 g Asacol per day. Postoperative recurrence is a significant problem but is significantly reduced by the prophylactic use of 5-aminosalicylic acid. |
| | |
Authors:
|
R S Mcleod |
Related Documents
:
|
6859783 - Proximal gastric vagotomy: a district general hospital experience. 2119183 - Consistent wound care and nutritional support in treatment. 17422443 - Routine use of protective sheaths in cattle inseminations did not improve fertility. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: The Netherlands journal of medicine Volume: 48 ISSN: 0300-2977 ISO Abbreviation: Neth J Med Publication Date: 1996 Feb |
Date Detail:
|
Created Date: 1997-01-21 Completed Date: 1997-01-21 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0356133 Medline TA: Neth J Med Country: NETHERLANDS |
Other Details:
|
Languages: eng Pagination: 68-70 Citation Subset: IM |
Affiliation:
|
Mount Sinai Hospital, University of Toronto, Ontario, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aminosalicylic Acids
/
therapeutic use* Anastomosis, Surgical / methods Anti-Inflammatory Agents, Non-Steroidal / therapeutic use* Crohn Disease / drug therapy*, prevention & control, surgery* Humans Mesalamine Postoperative Care* Recurrence |
| Chemical | |
Reg. No./Substance:
|
0/Aminosalicylic Acids; 0/Anti-Inflammatory Agents, Non-Steroidal; 89-57-6/Mesalamine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Selective immunomodulation in patients with inflammatory bowel disease--future therapy or reality?
Next Document: What is new in the treatment of perianal fistulae in Crohn's disease?